Drug intelligence / Profile preview

STAT-6 siRNA

Development stage
Preclinical
Lead developer
Roquefort Therapeutics
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Inhalation, Topical (intranasal/aerosol), Intravenous (in Vitro/ex Vivo Research)
01

Overview

STAT-6 siRNA is a small interfering RNA (siRNA) designed to specifically silence the expression of the signal transducer and activator of transcription 6 (STAT6) gene. STAT6 is a transcription factor involved in cytokine signaling pathways, particularly those mediated by interleukin-4 (IL-4), and plays a key role in immune responses as well as cancer cell proliferation. By targeting and degrading STAT6 mRNA via the RNA interference pathway, STAT-6 siRNA inhibits both mRNA and protein levels of STAT6 within cells. This results in reduced cell proliferation and increased apoptosis in various cancer cell lines that overexpress STAT6, such as colorectal, breast, lung adenocarcinoma cells, among others[4][5][1]. Preclinical studies have also explored its use for allergic diseases like asthma by delivering it locally to respiratory tract cells using liposomes or aerosolized formulations[2]. Delivery systems under investigation include gelatin nanocarriers for enhanced stability and cellular uptake[1].

Other names
Signal transducer and activator of transcription 6 small interfering RNAStat6 siRNA IStat-6 siRNA IStat 6 siRNA I
02

Targets

STAT6 (Signal Transducer and Activator of Transcription 6)

Beyond the preview

Go deeper on STAT-6 siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on STAT-6 siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call